Fresenius Medical Care AG & Co. KGaA
FMS | NYSE
$22.62
+$0.15 (+0.67%)
Nov 2, 2026, 3:59 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.86B | 4.61B | 5.07B | 4.88B | 4.79B | 4.88B | 5.08B | 4.76B | 4.77B | 4.72B | 4.99B | 4.94B | 4.83B | 4.7B | 5B | 5.1B | 4.76B | 4.55B | 4.65B | 4.44B | 4.32B | 4.21B |
Cost of Revenue | 3.55B | 3.43B | 3.68B | 3.64B | 3.58B | 3.7B | 3.81B | 3.61B | 3.6B | 3.55B | 3.64B | 3.71B | 3.63B | 3.56B | 3.65B | 3.85B | 3.51B | 3.37B | 3.33B | 3.17B | 3.04B | 3B |
Gross Profit | 1.31B | 1.18B | 1.39B | 1.24B | 1.21B | 1.18B | 1.27B | 1.15B | 1.17B | 1.17B | 1.35B | 1.23B | 1.2B | 1.15B | 1.35B | 1.24B | 1.25B | 1.17B | 1.32B | 1.27B | 1.28B | 1.21B |
Operating Income | 465.86M | 375.56M | 548.98M | 501.72M | 394.4M | 381.73M | 398.93M | 462.7M | 425M | 246.01M | 427.65M | 324M | 357M | 261M | 351.93M | 471.64M | 340.51M | 347.67M | 449.16M | 504.66M | 424.22M | 474.25M |
Interest Income | 14.7M | 14.62M | 13.62M | 19.16M | 21.85M | 14.98M | 21.58M | 17M | 18M | 15.66M | 26.87M | 25M | 24M | 12M | 24.75M | 16.05M | 12.75M | 14.11M | 28.36M | 15.59M | 13.97M | 15.26M |
Pretax Income | 383M | 207.52M | 508.46M | 402.57M | 350.55M | 250.65M | 179.12M | 380.53M | 340M | 157.83M | 343.06M | 235M | 276M | 178M | 276.62M | 395.16M | 268.93M | 278.57M | 382.44M | 436.23M | 355.01M | 398.18M |
Net Income | 218.38M | 117.53M | 327.08M | 274.8M | 225.27M | 151.22M | 66.9M | 213.03M | 187M | 70.96M | 187.93M | 84M | 140M | 86M | 138.8M | 230.1M | 147.14M | 157.36M | 228.74M | 273.04M | 218.58M | 248.95M |
Selling & General & Admin | 736.01M | 748.94M | 784.62M | 705.44M | 791.98M | 750.69M | 839.56M | 756.15M | 771M | 775.64M | 845.16M | 794M | 775M | 782M | 954.3M | 817.18M | 757.95M | 789.97M | 823.21M | 731.23M | 830.18M | 711.52M |
Research & Development | 39.63M | 38.31M | 38.63M | 37.75M | 38.12M | 43.48M | 50.06M | 40.05M | 46M | 47.8M | 65.99M | 53M | 57M | 56M | 62.05M | 61.48M | 55.42M | 49.67M | 67.76M | 52.36M | 52.02M | 48.65M |
Other Expenses | 68.49M | 16.69M | 16.14M | -2.69M | -10.14M | 8.08M | -18.13M | -112.81M | -76M | 104.19M | 10.87M | 58M | 8M | 50M | -20.76M | -106.81M | 91.69M | -13.46M | -20.96M | -21.04M | -22.42M | -27.76M |
Operating Expenses | 844.13M | 803.94M | 839.4M | 740.5M | 819.96M | 802.25M | 871.49M | 683.39M | 741M | 927.64M | 922.01M | 905M | 840M | 888M | 995.59M | 771.85M | 905.05M | 826.19M | 870.01M | 762.56M | 859.77M | 732.4M |
Interest Expense | 97.55M | 93.3M | 99.02M | 93.1M | 96.58M | 95.72M | 101.04M | 99M | 103M | 103.85M | 111.46M | 114M | 105M | 95M | 100.07M | 92.54M | 84.33M | 83.21M | 95.07M | 84.03M | 83.17M | 91.33M |
Selling & Marketing Expenses | n/a | 147.54M | 57.27M | 186.12M | 184.25M | 156.49M | 194.67M | 200.33M | 190.97M | 190.56M | n/a | 202.26M | n/a | 203.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.39B | 4.24B | 4.52B | 4.38B | 4.4B | 4.5B | 4.69B | 4.3B | 4.34B | 4.48B | 4.56B | 4.61B | 4.47B | 4.44B | 4.64B | 4.62B | 4.42B | 4.2B | 4.2B | 3.94B | 3.9B | 3.74B |
Income Tax Expense | 89.83M | 42.75M | 106.44M | 75.23M | 78.26M | 61.05M | 61M | 116.53M | 99M | 39.51M | 86.46M | 88M | 81M | 45M | 83.04M | 112.23M | 62.93M | 66.77M | 78.7M | 104.99M | 75.29M | 93.85M |
Shares Outstanding (Basic) | 539.2M | 550.44M | 571.81M | 584.67M | 586.83M | 586.83M | 1.17B | 1.17B | 1.17B | 1.17B | 879.91M | 879.91M | 879.91M | 879.91M | 1.17B | 1.17B | 1.17B | 1.17B | 887.33M | 887.33M | 887.33M | 887.33M |
Shares Outstanding (Diluted) | 539.2M | 550.44M | 571.81M | 584.67M | 586.83M | 586.83M | 1.17B | 1.17B | 1.17B | 1.17B | 879.91M | 879.91M | 879.91M | 879.91M | 1.17B | 1.17B | 1.17B | 1.17B | 887.33M | 887.33M | 887.33M | 887.33M |
EPS (Basic) | 0.41 | 0.22 | 0.57 | 0.47 | 0.39 | 0.26 | 0.06 | 0.19 | 0.16 | 0.06 | 0.22 | 0.10 | 0.16 | 0.10 | 0.12 | 0.20 | 0.13 | 0.14 | 0.26 | 0.31 | 0.25 | 0.28 |
EPS (Diluted) | 0.41 | 0.22 | 0.57 | 0.47 | 0.39 | 0.26 | 0.06 | 0.19 | 0.16 | 0.06 | 0.22 | 0.10 | 0.16 | 0.10 | 0.12 | 0.20 | 0.13 | 0.14 | 0.26 | 0.31 | 0.25 | 0.28 |
EBITDA | 823.01M | 763.76M | 981.03M | 852.92M | 822.37M | 740.73M | 757.13M | 845.89M | 830M | 774.12M | 880.45M | 803M | 815M | 710.81M | 871.36M | 989.68M | 775.26M | 780.74M | 914.62M | 923.08M | 833.72M | 877.71M |
EBIT | 465.86M | 300.82M | 607.48M | 495.66M | 447.14M | 346.37M | 280.13M | 479.63M | 443M | 261.68M | 454.51M | 349M | 381M | 273M | 376.69M | 487.69M | 353.26M | 361.78M | 477.51M | 520.25M | 438.19M | 489.51M |
Depreciation & Amortization | 357.16M | 462.94M | 373.55M | 357.26M | 375.24M | 394.36M | 477M | 366.26M | 387M | 512.44M | 425.93M | 454M | 434M | 437.81M | 494.67M | 501.98M | 422M | 418.96M | 437.11M | 402.83M | 395.53M | 388.2M |
Add to Watchlist
Select watchlists to add or remove FMS